Literature DB >> 4887203

Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.

E Mihich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4887203

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  22 in total

Review 1.  Adapting conventional cancer treatment for immunotherapy.

Authors:  Jian Qiao; Zhida Liu; Yang-Xin Fu
Journal:  J Mol Med (Berl)       Date:  2016-02-24       Impact factor: 4.599

2.  [Experimental investigations about the chemosensibility of transplantation tumors at different sites of transplantation].

Authors:  E Holst; U Sievers; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

3.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

4.  Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.

Authors:  M S Mitchell; M B Mokyr; J M Davis
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

5.  Evidence for host resistance in 1,3 bis(2-chloroethyl)-1-nitrosourea treatment induced in syngeneic LSA lymphoma.

Authors:  Y Maruyama; A Williams; J M Feola; C Nava
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

6.  Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas.

Authors:  G A Currie
Journal:  Br Med J       Date:  1970-02-28

7.  Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy.

Authors:  L Tentori; M P Fuggetta; S D'Atri; A Aquino; C Nunziata; M Roselli; P Ballatore; E Bonmassar; L De Vecchis
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Inhibition of a mouse hepatoma by the alkylating agent Trenimon linked to immunoglobulins.

Authors:  T Ghose; A Guclu; R R Raman; A H Blair
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

9.  Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy.

Authors:  S D'Atri; M P Fuggetta; G Giganti; L Tentori; M Roselli; C Nunziata; S Pastore; E Bonmassar; L De Vecchis
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Tumorigenicity of interleukin-2 (IL-2)-cDNA-transfected L1210 lymphoma and its in vivo variants is modulated by changes in IL-2 expression; potential therapeutic implications.

Authors:  P K Chakravarty; H Fuji; M M Abu-Hadid; S C Hsu; A K Sood
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.